Cargando…

Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies

Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Sung-Yeon, Lee, Dong-Gun, Kim, Won-Bok, Chun, Hye-Sun, Park, Chulmin, Myong, Jun-Pyo, Park, Yeon-Joon, Choi, Jae-Ki, Lee, Hyo-Jin, Kim, Si-Hyun, Park, Sun Hee, Choi, Su-Mi, Choi, Jung-Hyun, Yoo, Jin-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595445/
https://www.ncbi.nlm.nih.gov/pubmed/31018982
http://dx.doi.org/10.1128/JCM.02023-18
_version_ 1783430404529717248
author Cho, Sung-Yeon
Lee, Dong-Gun
Kim, Won-Bok
Chun, Hye-Sun
Park, Chulmin
Myong, Jun-Pyo
Park, Yeon-Joon
Choi, Jae-Ki
Lee, Hyo-Jin
Kim, Si-Hyun
Park, Sun Hee
Choi, Su-Mi
Choi, Jung-Hyun
Yoo, Jin-Hong
author_facet Cho, Sung-Yeon
Lee, Dong-Gun
Kim, Won-Bok
Chun, Hye-Sun
Park, Chulmin
Myong, Jun-Pyo
Park, Yeon-Joon
Choi, Jae-Ki
Lee, Hyo-Jin
Kim, Si-Hyun
Park, Sun Hee
Choi, Su-Mi
Choi, Jung-Hyun
Yoo, Jin-Hong
author_sort Cho, Sung-Yeon
collection PubMed
description Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collected all consecutive cases and clinical isolates of culture-positive proven/probable invasive aspergillosis patients from January 2016 to April 2018 and sampled the air inside and outside the hospital. Cryptic species-level identification of Aspergillus, antifungal susceptibilities, and cyp51 gene sequencing were performed, and clinical data were analyzed. This study was conducted as part of the Catholic Hematology Hospital Fungi Epidemiology (CAFÉ) study. A total of 207 proven/probable invasive aspergillosis and 102 clinical and 129 environmental Aspergillus isolates were included in this analysis. The incidence of proven/probable invasive aspergillosis was 1.3 cases/1,000 patient-days during the study period. Cryptic Aspergillus species accounted for 33.8%, with no differences in proportions between the clinical and environmental isolates. Section Nigri presented a high proportion (70.5%) of cryptic species, mainly from A. tubingensis and A. awamori: the former being dominant in environmental samples, and the latter being more common in clinical isolates (P < 0.001). Of 91 A. fumigatus isolates, azole-resistant A. fumigatus was found in 5.3% of all A. fumigatus isolates. Three isolates presented the TR(34)/L98H mutation of the cyp51A gene. Patients with invasive aspergillosis caused by azole-resistant A. fumigatus showed 100% all-cause mortality at 100 days. This study demonstrates the significant portion of cryptic Aspergillus species and clinical implications of azole resistance and underscores the comparison between clinical and environmental isolates.
format Online
Article
Text
id pubmed-6595445
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-65954452019-07-17 Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies Cho, Sung-Yeon Lee, Dong-Gun Kim, Won-Bok Chun, Hye-Sun Park, Chulmin Myong, Jun-Pyo Park, Yeon-Joon Choi, Jae-Ki Lee, Hyo-Jin Kim, Si-Hyun Park, Sun Hee Choi, Su-Mi Choi, Jung-Hyun Yoo, Jin-Hong J Clin Microbiol Mycology Global data on the epidemiology and susceptibility of Aspergillus are crucial in the management of invasive aspergillosis. Here, we aimed to determine the characteristics of clinical and environmental Aspergillus isolates, focusing mainly on hematologic malignancy patients. We prospectively collected all consecutive cases and clinical isolates of culture-positive proven/probable invasive aspergillosis patients from January 2016 to April 2018 and sampled the air inside and outside the hospital. Cryptic species-level identification of Aspergillus, antifungal susceptibilities, and cyp51 gene sequencing were performed, and clinical data were analyzed. This study was conducted as part of the Catholic Hematology Hospital Fungi Epidemiology (CAFÉ) study. A total of 207 proven/probable invasive aspergillosis and 102 clinical and 129 environmental Aspergillus isolates were included in this analysis. The incidence of proven/probable invasive aspergillosis was 1.3 cases/1,000 patient-days during the study period. Cryptic Aspergillus species accounted for 33.8%, with no differences in proportions between the clinical and environmental isolates. Section Nigri presented a high proportion (70.5%) of cryptic species, mainly from A. tubingensis and A. awamori: the former being dominant in environmental samples, and the latter being more common in clinical isolates (P < 0.001). Of 91 A. fumigatus isolates, azole-resistant A. fumigatus was found in 5.3% of all A. fumigatus isolates. Three isolates presented the TR(34)/L98H mutation of the cyp51A gene. Patients with invasive aspergillosis caused by azole-resistant A. fumigatus showed 100% all-cause mortality at 100 days. This study demonstrates the significant portion of cryptic Aspergillus species and clinical implications of azole resistance and underscores the comparison between clinical and environmental isolates. American Society for Microbiology 2019-06-25 /pmc/articles/PMC6595445/ /pubmed/31018982 http://dx.doi.org/10.1128/JCM.02023-18 Text en Copyright © 2019 Cho et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Mycology
Cho, Sung-Yeon
Lee, Dong-Gun
Kim, Won-Bok
Chun, Hye-Sun
Park, Chulmin
Myong, Jun-Pyo
Park, Yeon-Joon
Choi, Jae-Ki
Lee, Hyo-Jin
Kim, Si-Hyun
Park, Sun Hee
Choi, Su-Mi
Choi, Jung-Hyun
Yoo, Jin-Hong
Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies
title Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies
title_full Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies
title_fullStr Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies
title_full_unstemmed Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies
title_short Epidemiology and Antifungal Susceptibility Profile of Aspergillus Species: Comparison between Environmental and Clinical Isolates from Patients with Hematologic Malignancies
title_sort epidemiology and antifungal susceptibility profile of aspergillus species: comparison between environmental and clinical isolates from patients with hematologic malignancies
topic Mycology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595445/
https://www.ncbi.nlm.nih.gov/pubmed/31018982
http://dx.doi.org/10.1128/JCM.02023-18
work_keys_str_mv AT chosungyeon epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT leedonggun epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT kimwonbok epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT chunhyesun epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT parkchulmin epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT myongjunpyo epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT parkyeonjoon epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT choijaeki epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT leehyojin epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT kimsihyun epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT parksunhee epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT choisumi epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT choijunghyun epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies
AT yoojinhong epidemiologyandantifungalsusceptibilityprofileofaspergillusspeciescomparisonbetweenenvironmentalandclinicalisolatesfrompatientswithhematologicmalignancies